Inherited predisposition and breast cancer: Modifiers of BRCA1/2-associated breast cancer risk

Environmental and Molecular Mutagenesis

Volumn 39, Issue 2-3, 2002, Pages 228-234

  Rebbeck, Timothy R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

BRCA1 2 mutation carriers; Germline mutation; Inherited predisposition; Interindividual variability; Risk modification

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; FEMALE; GENE MUTATION; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETIC RISK; HORMONE METABOLISM; HUMAN; ONCOGENE; OVARY CANCER;

BREAST NEOPLASMS; EPIDEMIOLOGIC FACTORS; FEMALE; GENE FREQUENCY; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 0036205724     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10050     Document Type: Conference Paper

References (44)

1. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk
2. Polymorphisms in XRCC1 and XPD as breast cancer risk modifiers in BRCA1 mutation carriers
3. BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer
4. The effect of smoking on BC in BRCA1 and BRCA2 carriers
5. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function
6. Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers
7. BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation
8. Genetic linkage analysis in familial breast ovarian cancer: Results from 214 families
9. Age at first birth, parity and risk of breast cancer: A meta-analysis of 8 studies from the Nordic countries
10. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients
11. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation
12. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene
13. A large kindred with 17q-linked breast and ovarian cancer: Genetic, phenotypic, and genealogical analysis
14. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer
15. BRCA1 mutations and phenotype
16. Hormone-dependent regulation of BRCA1 in human breast cancer cells
17. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells
18. Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2
19. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length
20. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2
21. Reproductive factors in hereditary breast cancer
22. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers
23. Reproductive factors in breast cancer
24. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers
25. BRCA1 expression is not directly responsive to estrogen
26. Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer
27. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation
28. The mammalian SWI/SNF complex and the control of cell growth
29. Risk modifiers in carriers of BRCA1 mutations
30. Oral contraceptives and the risk of hereditary ovarian cancer
31. Breast cancer susceptibility gene 1 (BRCA1) is a coactivator of the androgen receptor
32. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeats (VNTR) locus
33. Association of breast cancer incidence with NAT2 genotype and smoking in BRCA1 variant carders
34. Modification of BRCA1-associated breast cancer penetrance by androgen receptor CAG repeat length variants
35. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history
36. BRCA1 is a component of the RNA polymerase II holoenzyme
37. Association of BRCA1 with Rad51 in mitotic and meiotic cells
38. The risk of cancer associated with specific variants of BRCA1 and BRCA2 among Ashkenazi Jews
39. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers
40. Variation of BRCA1 cancer risks by mutation position
41. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?
42. A single nucleotide polymorphism in the 5′ untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers
43. The HRAS1 minisatellite locus and risk of ovarian cancer
44. Insights into the functions of BRCA1 and BRCA2